Biomarin Pharmaceutical Inc (BMRN)
91.22
-0.82
(-0.89%)
USD |
NASDAQ |
Apr 24, 16:00
87.90
-3.32
(-3.64%)
After-Hours: 20:00
Biomarin Pharmaceutical Cash from Financing (TTM): -18.73M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.73M |
| September 30, 2023 | -18.70M |
| June 30, 2023 | -10.37M |
| March 31, 2023 | -34.11M |
| December 31, 2022 | -18.65M |
| September 30, 2022 | -15.12M |
| June 30, 2022 | -23.70M |
| March 31, 2022 | -0.964M |
| December 31, 2021 | -0.048M |
| September 30, 2021 | -380.60M |
| June 30, 2021 | -376.31M |
| March 31, 2021 | 176.42M |
| December 31, 2020 | 181.12M |
| September 30, 2020 | 551.32M |
| June 30, 2020 | 546.08M |
| March 31, 2020 | -69.36M |
| December 31, 2019 | -74.67M |
| September 30, 2019 | -445.08M |
| June 30, 2019 | -437.95M |
| March 31, 2019 | -403.22M |
| December 31, 2018 | -388.01M |
| September 30, 2018 | -8.549M |
| June 30, 2018 | 468.24M |
| March 31, 2018 | 504.12M |
| December 31, 2017 | 507.14M |
| Date | Value |
|---|---|
| September 30, 2017 | 513.96M |
| June 30, 2017 | 769.03M |
| March 31, 2017 | 757.63M |
| December 31, 2016 | 727.11M |
| September 30, 2016 | 716.71M |
| June 30, 2016 | -16.53M |
| March 31, 2016 | -26.33M |
| December 31, 2015 | 925.72M |
| September 30, 2015 | 957.73M |
| June 30, 2015 | 962.83M |
| March 31, 2015 | 962.02M |
| December 31, 2014 | 184.20M |
| September 30, 2014 | 847.60M |
| June 30, 2014 | 851.03M |
| March 31, 2014 | 869.81M |
| December 31, 2013 | 746.67M |
| September 30, 2013 | 81.31M |
| June 30, 2013 | 79.31M |
| March 31, 2013 | 312.67M |
| December 31, 2012 | 312.29M |
| September 30, 2012 | 283.17M |
| June 30, 2012 | 280.62M |
| March 31, 2012 | 39.55M |
| December 31, 2011 | 29.34M |
| September 30, 2011 | 8.825M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-445.08M
Minimum
Sep 2019
551.32M
Maximum
Sep 2020
-24.71M
Average
-18.70M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
| Eli Lilly and Co | 3.496B |
| Merck & Co Inc | -4.81B |
| Pfizer Inc | 26.07B |
| Bristol-Myers Squibb Co | -9.416B |
| Moderna Inc | -1.377B |